WO2001091723A3 - Fluorinated copolymer surfactants and use thereof in aerosol compositions - Google Patents
Fluorinated copolymer surfactants and use thereof in aerosol compositions Download PDFInfo
- Publication number
- WO2001091723A3 WO2001091723A3 PCT/US2001/017111 US0117111W WO0191723A3 WO 2001091723 A3 WO2001091723 A3 WO 2001091723A3 US 0117111 W US0117111 W US 0117111W WO 0191723 A3 WO0191723 A3 WO 0191723A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fluorinated copolymer
- aerosol compositions
- copolymer surfactants
- particles
- surfactants
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
Abstract
Amphiphilic fluorinated block copolymers are disclosed which are useful for increasing the dispersability of particles, preferably drug particles, in a fluorine-containing propellant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001265025A AU2001265025A1 (en) | 2000-05-26 | 2001-05-25 | Fluorinated copolymer surfactants and use thereof in aerosol compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/580,008 US6451287B1 (en) | 2000-05-26 | 2000-05-26 | Fluorinated copolymer surfactants and use thereof in aerosol compositions |
US09/580,008 | 2000-05-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001091723A2 WO2001091723A2 (en) | 2001-12-06 |
WO2001091723A3 true WO2001091723A3 (en) | 2003-04-03 |
Family
ID=24319264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/017111 WO2001091723A2 (en) | 2000-05-26 | 2001-05-25 | Fluorinated copolymer surfactants and use thereof in aerosol compositions |
Country Status (3)
Country | Link |
---|---|
US (1) | US6451287B1 (en) |
AU (1) | AU2001265025A1 (en) |
WO (1) | WO2001091723A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
GB0125127D0 (en) * | 2001-10-19 | 2001-12-12 | Glaxo Group Ltd | Compounds |
GB0130703D0 (en) * | 2001-12-21 | 2002-02-06 | Glaxo Group Ltd | Particles |
JP2005517701A (en) * | 2002-02-13 | 2005-06-16 | グラクソ グループ リミテッド | Carboxylic acid compounds for use as surfactants |
GB0205327D0 (en) * | 2002-03-06 | 2002-04-17 | Glaxo Group Ltd | compounds |
US7632916B2 (en) | 2002-08-02 | 2009-12-15 | 3M Innovative Properties Company | Process to modify polymeric materials and resulting compositions |
US6903173B2 (en) | 2002-08-02 | 2005-06-07 | 3M Innovative Properties Co. | Fluorinated polymers |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
US20060211589A1 (en) * | 2003-07-31 | 2006-09-21 | Godfrey Anne P | Pharmaceutical metered dose inhaler and methods relating thereto |
MXPA06001642A (en) * | 2003-08-11 | 2006-04-28 | Glaxo Group Ltd | Pharmaceutical metered dose inhaler and methods relating thereto. |
CN100412101C (en) * | 2006-01-27 | 2008-08-20 | 苏州大学 | Amphipathic fluoride block copolymer and production thereof |
CN100376614C (en) * | 2006-02-21 | 2008-03-26 | 苏州大学 | Fluorine-contg. block copolymers of pH-responsed and its prepn. method |
CN104188907A (en) | 2007-02-11 | 2014-12-10 | Map药物公司 | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0636362A2 (en) * | 1990-03-23 | 1995-02-01 | Minnesota Mining And Manufacturing Company | The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4352789A (en) | 1980-03-17 | 1982-10-05 | Minnesota Mining And Manufacturing Company | Aerosol compositions containing finely divided solid materials |
US4608401A (en) | 1982-09-02 | 1986-08-26 | Union Carbide Corporation | Method of encapsulating finely divided solid particles |
US4771086A (en) | 1982-09-02 | 1988-09-13 | Union Carbide Corporation | Encapsulating finely divided solid particles in stable suspensions |
US4486572A (en) * | 1983-07-06 | 1984-12-04 | University Of Akron | Synthesis of amphiphilic block copolymers and networks |
US5320906A (en) | 1986-12-15 | 1994-06-14 | Vestar, Inc. | Delivery vehicles with amphiphile-associated active ingredient |
US4755563A (en) | 1986-12-29 | 1988-07-05 | E. I. Du Pont De Nemours And Company | Block copolymer dispersants containing ionic moieties |
GB8828477D0 (en) | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
IL97065A (en) | 1990-02-02 | 1994-01-25 | Fisons Plc | Aerosol propellant compositions |
US5118494A (en) | 1990-03-23 | 1992-06-02 | Minnesota Mining And Manufacturing Company | Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
US5126123A (en) | 1990-06-28 | 1992-06-30 | Glaxo, Inc. | Aerosol drug formulations |
CA2085884C (en) | 1990-06-29 | 2001-12-04 | Asit Somani | Pressurized hydrofluorocarbon aerosol compositions |
US5518731A (en) | 1990-09-27 | 1996-05-21 | Allergan, Inc. | Nonaqueous fluorinated drug delivery vehicle suspensions |
US5639441A (en) | 1992-03-06 | 1997-06-17 | Board Of Regents Of University Of Colorado | Methods for fine particle formation |
US5496901A (en) | 1992-03-27 | 1996-03-05 | University Of North Carolina | Method of making fluoropolymers |
US5376359A (en) | 1992-07-07 | 1994-12-27 | Glaxo, Inc. | Method of stabilizing aerosol formulations |
US5492688A (en) | 1993-04-28 | 1996-02-20 | The Center For Innovative Technology | Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent |
US5312882A (en) | 1993-07-30 | 1994-05-17 | The University Of North Carolina At Chapel Hill | Heterogeneous polymerization in carbon dioxide |
US5612431A (en) | 1994-09-21 | 1997-03-18 | Minnesota Mining And Manufacturing Company | Leaching of precious metal ore with fluoroaliphatic surfactant |
GB9419536D0 (en) | 1994-09-28 | 1994-11-16 | Glaxo Inc | Medicaments |
US6013245A (en) | 1995-01-26 | 2000-01-11 | Glaxo Group Limited | Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant |
TWI230712B (en) * | 1998-09-15 | 2005-04-11 | Novartis Ag | Polymers |
-
2000
- 2000-05-26 US US09/580,008 patent/US6451287B1/en not_active Expired - Fee Related
-
2001
- 2001-05-25 AU AU2001265025A patent/AU2001265025A1/en not_active Abandoned
- 2001-05-25 WO PCT/US2001/017111 patent/WO2001091723A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0636362A2 (en) * | 1990-03-23 | 1995-02-01 | Minnesota Mining And Manufacturing Company | The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
Non-Patent Citations (1)
Title |
---|
CANELAS DORIAN; YATES MATTHEW: "Poly(vinyl acetate) and Poly(vinyl acetate-co-ethylene) Latexes via Dispersion Polymerizations in Carbon Dioxide", MACROMOLECULES, vol. 31, no. 20, 1998, pages 6794 - 6805, XP002213042 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001265025A1 (en) | 2001-12-11 |
US6451287B1 (en) | 2002-09-17 |
WO2001091723A2 (en) | 2001-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001091723A3 (en) | Fluorinated copolymer surfactants and use thereof in aerosol compositions | |
MY139066A (en) | Polymeric microemulsions | |
AU2001280597A1 (en) | Compositions for sustained release of analgesic agents, and methods of making and using the same | |
WO2005039551A3 (en) | Solid pharmaceutical dosage form comprising an hiv protease inhibitor solid dispersion | |
AU2001224698A1 (en) | Physically crosslinked amphiphilic networks, methods of preparation, and uses thereof | |
EP1223212A3 (en) | Compositions and methods for using amine oxide monomeric unit-containing polymeric suds enhancers | |
AU2002349190A1 (en) | Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof | |
AU2003225915A1 (en) | Formoterol and mometasone aerosol formulations | |
GB0026054D0 (en) | Films,compositions and processes | |
MXPA03004828A (en) | Liquid dispersion polymer compositions, their preparation and their use. | |
WO2002003750A3 (en) | Improved directional microphone system | |
WO2002085338A3 (en) | Ipratropium formulation for pulmonary inhalation | |
AU2002214583A1 (en) | Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof | |
AU2002241508A1 (en) | Membrane derived caspase-3, compositions comprising the same and methods of use therefor | |
WO2001098516A3 (en) | Siderophores-producing bifidobacteria thereby and uses thereof | |
WO2002036145A3 (en) | Kahalalide f formulation | |
AU2001235773A1 (en) | Electro-luminiscent polymers, their preparation and uses | |
AU2002358547A1 (en) | Mixtures comprising 1,1,1,3,3-pentafluorobutane and 1,1,1,2,3,3,3-heptafluoropropane | |
AU2002360547A1 (en) | Monoterpene compositions and uses thereof | |
WO2003054025A3 (en) | Amphoteric polysaccharide, composition and use | |
WO2005009407A3 (en) | Oral pharmaceutical formulations of olanzapine | |
AU2002255649A1 (en) | Band 3 antigenic peptides, malaria polypeptides and uses thereof | |
AU2001229439A1 (en) | Bioconjugates and uses thereof | |
WO2001079288A3 (en) | Cytokine uses; compositions; methods | |
WO2002000191A3 (en) | Bdellosomes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |